ASTRO 2025: At 10 years, SBRT comparable to surgery for early-stage lung cancer
Reports and Proceedings
Updates every hour. Last Updated: 30-Dec-2025 07:11 ET (30-Dec-2025 12:11 GMT/UTC)
Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body radiation therapy (SBRT) and surgery achieved similar survival outcomes at 10-year follow-up for patients with early-stage non-small cell lung cancer, with radiation offering quality-of-life benefits. These findings will be presented Sept. 29 by Joe Chang, M.D., Ph.D., professor of Radiation Oncology, and Troy Kleber, M.D., resident.
Microscale biological robots made from human lung cells are advancing in Carnegie Mellon's Ren lab, with new research showing control over their movement via engineered structural design.
A new study led by Boston University School of Public Health captures the first data in decades on the relationship between maternal deaths and infant health and deaths, finding that infants are much more likely to die or be hospitalized for poor health if their mother experiences a pregnancy-associated death or severe illness. Published in the journal Obstetrics & Gynecology, the study examined maternal and infant health and mortality rates in Massachusetts from 1999 to 2021 and found that in cases when the mother died during pregnancy or the postpartum period, the infant mortality rate was more than 14 times as high as in cases when the mother did not die during this period. When maternal deaths occurred after mothers experienced severe maternal morbidity, the infant mortality rate was 22 times greater than when the mother survived the postpartum period.